For 2023, Ford has given the Escape Hybrid a styling makeover and equipped it with an updated infotainment system, which is sure to resonate with tech-focused buyers. But what the Escape Hybrid needed ...

It's been a banner year for anime as its popularity has grown exponentially and American animation looks towards the trailblazing Japanese form to reshape how it tells stories. But while series like ...

Pinterest searches for medieval fashion are surging, and the global mead market is set to double by 2032. These clear signs of a growing fascination with history are spilling into everyday life, where ...

Health care spending in the US reached $4.9 trillion and increased 7.5 percent in 2023, growing from a rate of 4.6 percent in 2022. In 2023, the insured share of the population reached 92.5 percent, ...

In 2023, Transparency International worked as a united, global force for change. We have one vision: a world in which government, business, civil society and the daily lives of people are free of ...

WASHINGTON, June 26, 2024—After a period of strong growth during 2021-2022, officially recorded remittance flows to low- and middle-income countries (LMICs) moderated in 2023, reaching an estimated ...

More than a million abortions were provided in the U.S. in 2023. That's a major finding from a report published Tuesday by the Guttmacher Institute, a research organization that supports access to ...

The season is over. A champion has been crowned. All that's left is to deliver a final, comprehensive ranking of every quarterback who started a game in 2023, judging them by the entire regular season ...

We've already rounded up the list of overall bestselling vehicles in the U.S. for 2023, and now we're diving deeper into the numbers to look more closely at an important segment of the market: ...

The U.S. labor market ended the year strong, creating more than 200,000 jobs in the last month of the year and nearly 2.7 million jobs in all of 2023, when seasonally adjusted. Consumer spending ...

The FDA’s Center for Drug Evaluation and Research (CDER) approved 55 new drugs in 2023, as the small molecule and biologic pharmacopoeia continues to grow. This cohort is nearly 50% bigger than the ...

2023 was a big year for cybersecurity, with significant cyberattacks, data breaches, new threat groups emerging, and, of course, zero-day vulnerabilities. Some stories, though, were more impactful or ...